Company Filing History:
Years Active: 2005-2007
Title: Veronique Plantevin: Innovator in JNK Inhibitors
Introduction
Veronique Plantevin is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as selective inhibitors of JNK (c-Jun N-terminal kinase). With a total of 5 patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Among her latest patents, Veronique has developed methods of using indazole derivatives as JNK inhibitors. These compounds are designed to treat a wide range of conditions that respond to JNK inhibition. The patents disclose pharmaceutical compositions containing these indazole derivatives, which have shown utility in treating inflammatory diseases and disorders.
Career Highlights
Veronique Plantevin is currently associated with Signal Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her research focuses on the therapeutic applications of indazole compounds, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Veronique has collaborated with notable colleagues, including Shripad S Bhagwat and Yoshitaka Satoh. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Veronique Plantevin is a trailblazer in the development of JNK inhibitors, with a strong portfolio of patents that reflect her innovative spirit. Her work at Signal Pharmaceuticals, Inc. continues to pave the way for new treatments in the pharmaceutical industry.